• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手指腱鞘巨细胞瘤的显微外科切除——手指腱鞘巨细胞瘤的显微手术

Microsurgical resection of tenosynovial giant cell tumor in the digits microsurgery for digital GCT.

作者信息

Muramatsu Keiichi, Tani Yasuhiro, Ueda Masaya, Carolino Daniela Kristina D, Sugimoto Hideaki

机构信息

Department of Hand Surgery, Nagato General Hospital, 85 Higashi-fukawa, Nagato, Yamaguchi, 759-4194, Japan.

出版信息

J Hand Microsurg. 2025 May 21;17(4):100283. doi: 10.1016/j.jham.2025.100283. eCollection 2025 Jul.

DOI:10.1016/j.jham.2025.100283
PMID:40510296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12158499/
Abstract

BACKGROUND

Tenosynovial giant cell tumor (TGCT) is a benign tumor arising from the synovial tissue and frequently occur in the digits. The treatment is surgical excision, but a high local recurrence rate is reported. The utilization of the surgical microscope during resection of digital TGCTs appears to be beneficial for more detailed visualization. We presented the outcomes of microsurgical resection of TGCT and discussed how to prevent recurrence of TGCT.

METHODS

We reviewed 34 consecutive patients with TGCT cases operated by the single operator. The age at surgery ranged from 9 to 77 years, with an average of 48. The most common affected digit was the thumb (n = 13). In all cases, an operating microscope was utilized. The postoperative follow-up period was an average of 27.6 months.

RESULTS

Intraoperative findings with the use of a microscope revealed an unexpectedly large number of cases with continuity to the adjacent joints. In cases of joint invasion, the capsule was opened to directly visualize the inside of the joint, and intra-articular tumor was resected enbloc together with extra-articular components. The classification of the disease was mixed type in 17 digits, localized type in 17. Postoperative recurrence was found in only one case (2.9 %).

CONCLUSION

Microsurgery may be a beneficial tool for TGCT resection, but there have been only few reports. Invasive TGCT into the volar plate or infiltrating into the bone near the tendon attachment are well visualized and could be more certainly resected. The recurrence rate after microscopic TGCT resection was only 2.9 %, which is probably the lowest rate in the previously reported literature. Microsurgery allows sufficient visualization of the TGCT invasion and is useful for dissection of digital nerves and arteries.

摘要

背景

腱鞘巨细胞瘤(TGCT)是一种起源于滑膜组织的良性肿瘤,常见于手指部位。治疗方法为手术切除,但据报道局部复发率较高。在切除手指TGCT时使用手术显微镜似乎有助于更清晰地观察。我们展示了TGCT显微手术切除的结果,并讨论了如何预防TGCT复发。

方法

我们回顾了由同一手术医生连续治疗的34例TGCT患者。手术年龄范围为9至77岁,平均年龄48岁。最常受累的手指是拇指(n = 13)。所有病例均使用了手术显微镜。术后平均随访期为27.6个月。

结果

使用显微镜的术中发现显示,与相邻关节相连的病例数量出乎意料地多。在关节受累的病例中,打开关节囊直接观察关节内部,将关节内肿瘤与关节外成分整块切除。疾病分类为混合型17指,局限型17指。仅1例(2.9%)出现术后复发。

结论

显微手术可能是TGCT切除的一种有益工具,但相关报道较少。侵入掌板或浸润到肌腱附着处附近骨骼的TGCT能够清晰观察到,并且可以更确切地切除。TGCT显微切除术后的复发率仅为2.9%,这可能是既往文献报道中最低的复发率。显微手术能够充分观察TGCT的侵袭情况,并且有助于分离手指的神经和动脉。

相似文献

1
Microsurgical resection of tenosynovial giant cell tumor in the digits microsurgery for digital GCT.手指腱鞘巨细胞瘤的显微外科切除——手指腱鞘巨细胞瘤的显微手术
J Hand Microsurg. 2025 May 21;17(4):100283. doi: 10.1016/j.jham.2025.100283. eCollection 2025 Jul.
2
What Are the Recurrence Rates, Complications, and Functional Outcomes After Multiportal Arthroscopic Synovectomy for Patients With Knee Diffuse-type Tenosynovial Giant-cell Tumors?膝关节弥漫型腱鞘巨细胞瘤患者行多入路关节镜下滑膜切除术的复发率、并发症及功能结局如何?
Clin Orthop Relat Res. 2024 Jul 1;482(7):1218-1229. doi: 10.1097/CORR.0000000000002934. Epub 2023 Dec 28.
3
The economic and humanistic burden of tenosynovial giant cell tumor: a targeted literature review.腱鞘巨细胞瘤的经济和人文负担:一项针对性文献综述
Future Oncol. 2025 Aug;21(18):2385-2400. doi: 10.1080/14796694.2025.2520744. Epub 2025 Jun 22.
4
Real-world experience of patients newly initiated on pexidartinib for tenosynovial giant cell tumor.培西达替尼新用于腱鞘巨细胞瘤患者的真实世界经验。
Future Oncol. 2025 Jul 4:1-10. doi: 10.1080/14796694.2025.2527586.
5
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
10
Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.术中冰冻切片分析用于诊断可疑盆腔肿块中的早期卵巢癌。
Cochrane Database Syst Rev. 2016 Mar 1;3(3):CD010360. doi: 10.1002/14651858.CD010360.pub2.

本文引用的文献

1
Giant Cell Tumor of the Tendon Sheath of the Hand: Analysis of Factors Impacting Recurrence.手部腱鞘巨细胞瘤:影响复发因素的分析
Indian J Plast Surg. 2024 Feb 21;57(2):123-128. doi: 10.1055/s-0044-1779657. eCollection 2024 Apr.
2
Treatment, recurrence rates and follow-up of Tenosynovial Giant Cell Tumor (TGCT) of the foot and ankle-A systematic review and meta-analysis.足部和踝关节腱鞘巨细胞瘤(TGCT)的治疗、复发率和随访-系统评价和荟萃分析。
PLoS One. 2021 Dec 2;16(12):e0260795. doi: 10.1371/journal.pone.0260795. eCollection 2021.
3
Schwannoma in the extremity: clinical features and microscopic intra-capsular enucleation.肢体神经鞘瘤:临床特征及显微镜下囊内摘除术
J Rural Med. 2021 Oct;16(4):184-190. doi: 10.2185/jrm.2021-020. Epub 2021 Oct 1.
4
Outcomes of surgery for giant cell tumors of the tendon sheath within the hand.手部腱鞘巨细胞瘤手术治疗的结果。
Pol Przegl Chir. 2020 Sep 28;92(6):16-21. doi: 10.5604/01.3001.0014.4136.
5
Tenosynovial Giant Cell Tumor in the Hand: Experience with 173 Cases.手部腱鞘巨细胞瘤:173例经验
J Hand Surg Asian Pac Vol. 2020 Jun;25(2):158-163. doi: 10.1142/S2424835520500174.
6
Giant cell tumor of tendon sheath in the hand: analysis of risk factors for recurrence in 50 cases.手部腱鞘巨细胞瘤:50 例复发危险因素分析。
BMC Musculoskelet Disord. 2019 Oct 21;20(1):457. doi: 10.1186/s12891-019-2866-8.
7
Subungual glomus tumours: diagnosis and microsurgical excision through a lateral subperiosteal approach.甲下血管球瘤:经外侧骨膜下切开术诊断和显微切除。
J Plast Reconstr Aesthet Surg. 2014 Mar;67(3):373-6. doi: 10.1016/j.bjps.2013.11.006. Epub 2013 Nov 21.
8
Giant cell tumor of tendon sheath: study of 64 cases and review of literature.腱鞘巨细胞瘤:64例研究及文献复习
G Chir. 2013 May-Jun;34(5-6):149-52. doi: 10.11138/gchir/2013.34.5.149.
9
Giant cell tumour of tendon sheath of the digits. A systematic review.手指腱鞘巨细胞瘤。一项系统评价。
Hand (N Y). 2011 Sep;6(3):244-9. doi: 10.1007/s11552-011-9341-9. Epub 2011 Jun 1.
10
Giant cell tumours of tendon sheath of hand: causes and strategies to prevent recurrence.手部腱鞘巨细胞瘤:病因及预防复发的策略
Hand Surg. 2011;16(2):149-54. doi: 10.1142/S0218810411005242.